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I-j is a cell surface molecule having unique genetic polymorphism linked to
the murine MHC (1, 2). This has been supported by a number ofstudies using
Tcell hybridomas and clones with continuous I-j expression detected by anti-1-j
mAb (3-10). The expression of 1-j is generally associated with a known T cell
function, suggesting that I-j itself is involved in a site essential for the T cell
function . Although these notions compelled us to conclude that I-j is a genetic
marker controlled by a locus mapped within the I region of MHC, recent
molecular analyses of MHC have excluded the presence ofthe I-j structural gene
within the MHC chromosomal segment (11-14).
Because I-j had solely been defined by the specificity of alloantibodies, we
reexamined the effect of anti-IJ mAb on T cell functions to find that anti-1-j'
mAb block syngeneic and allogeneic mixed lymphocyte reactions (MLR) ofH-2k
by reacting with the responder but not with stimulator cells (15). This target
specificity was distinct from the effect of conventional anti-class II antibodies,
and confirmed the notion that IJ is on T cells but not on macrophages and B
cells. It also suggested that I-j epitopes are in association with a recognition
structure for self- and allo-class II antigens.
In previous reports (16, 17), we demonstrated thatanother I region-controlled
determinant selectively expressed on T cells (Iat) is not the direct product of I
region genes but is associated with the T cell receptor that sees the self Ia. The
epitopes were found to undergo systematic adaptive alterations according to the
acquisition of a new MHC restriction specificity in radiation bone marrow
chimeras (17). Therefore, we hypothesized that I-j is not a mere genetic marker,
but is associated with the T cells' recognition site for a self MHC. In the present
study, the nature of I-j epitope on the MHC-restricted Th cells was analyzed by
using radiation bone marrow chimeras constructed by the combination ofintra-
H-2 recombinant mice. The contradictory expression of I-j epitopes on Th cells
will be described, and its biological significance will be discussed.
Materials and Methods
Animals. C57BL/6 (B6), C57BL/10 (B10), B10.BR, B10.A, C3H, (B6 x A/J)F,
(B6AF,), (B6 x C3H)F, (B6C3F,), BALB/c nu/nu mice were purchasedfrom theShizuoka
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Agricultural Cooperative Association for Laboratory Animals, Hamamatsu, Japan.
BII1.A(3R) (3R), B10.A(4R) (4R), Bl0.A(5R) (5R), (B10 x B10.BR)F,, (B10 x B10.A)F,,
and (4R x 5R)F, mice were bred in our animal facility.
Chimeras.
￿
Chimeras used in this study were prepared as previously described(18), and
were designated as bone marrow donor -+ irradiated recipient. Chimeras were used no
earlier than 8 wk after irradiation and reconstitution. Spleen cells of chimeric mice were
examined to ascertain their donor origin by the cytotoxicity assay with anti-H-2 reagents
where <5% of cells were found to be of host origin.
Antigens.
￿
Keyhole limpet hemocyanin (KLH)' (Calbiochem-Behring, San Diego, CA)
was conjugated with 2,4,6-trinitrobenzene sulfonic acid (Pierce Chemical Co., Rockford,
IL) (TNP-KLH) as previously described (19). The substitution rate was 20 TNP residues
per 100 kD KLH.
Antibodies.
￿
Anti-IJ" mAb (168, 4BII, and KN34) are those described in detail in
previous papers (15). They are the products of hybridomas derived from spleen cells of
3R immune to 5R lymphoid cellsand have been selected by theirreactivity with suppressor
T cell (Ts) hybridomas and clones expressing I-J' determinant(s). JK 10-23 is a newly
established monoclonal anti-IJ" produced through a similar manner. Ascites containing
mAb were produced in BALB/c nu/nu mice. This antibody was able to absorb T
suppressor factor (TsF) from KLH-primed T cells of H-2" mice but not of other strains.
Anti-H-2° and anti-H-2" antisera were prepared as previously described (17). Anti-H-2 K"
mAb (11-4.1) (20) was obtained from the Salk Institute Cell Distribution Center, San
Diego, CA . Anti-H-2K6 mAb (28-13-Bs) (21) was a gift from Dr. D. H. Sachs, National
Institutes of Health, Bethesda, MD. Anti-H-2W mAb (H141-30) was made by Dr. G.
Himmerling (German Cancer Center, Heidelberg, Federal Republic of Germany). Anti-
L3T4a mAb (GK1 .5) (22) was made by Dr. F. W. Fitch, University of Chicago, Chicago,
IL. Cytotoxic treatmentof T cells was carried out at 10" cells/ml with thepredetermined
dilution of the antibody and selected rabbit complement (C).
Immunization.
￿
Mice were immunized with 100 tcg of KLH or TNP-KLH incomplete
Freund's adjuvant (Difco Laboratories, Detroit, MI) intraperitoneally. Fully allogeneic
chimeras were immunized with KLH-pulsed irradiated host type accessory (Acc) cells as
described previously (23). Briefly, unprimed spleen cells were depleted of T cells by the
treatment with a T cell-specific rabbit anti-mouse brain serum (RAMB) + C followed by
3,000 rad irradiation. The cells were pulsed with antigen by incubating with 100 Ag/ml
of KLH in RPMI 1640 medium containing 10% FCS.
Preparation of Cells.
￿
B cells were prepared by treating the TNP-KLH-primed spleen
cells with RAMB + C (19). T cells were separated by panning the KLH-primed spleen
cells on anti-mouse immunoglobulin-coated plastic dishes (19). Nonadherent cells con-
sisting of >95% Thy-I+ cells were used as Th cells.
Culture Conditionsfor the In Vitro Antibody Responses.
￿
The in vitrosecondary antibody
response was induced as previously described (19). Briefly, the mixture of 3 x 106 TNP-
prinied B cells and 106 KLH-primed Th cells was incubated with 1 ng/ml TNP-KLH in a
volume of 2 ml per 16-mm-diam flat-bottomed well (3524; Costar, Cambridge, MA) for
5 d at 37°C in 5% COY humidified air atmosphere. Medium used was RPMI 1640
supplemented with 2 MM L-glutamine, 1 mM sodium pyruvate, nonessential aminoacids,
5 x 10-s M 2-ME, and 10% FCS. Harvested cells were assayed for plaque-forming cells
(PFC) on TNP-conjugated sheep erythrocyte (19). All points shown in each experiment
represent the arithmetic mean IgG PFC responsesof identical triplicate cultures.
Limiting-dilution Analysis.
￿
The frequency of Th cells was estimated by the limiting-
dilution analysis (24). Graded doses of KLH-primed F, Th cells were cultured with 5 x
10' TNP-primed parental B cells in the presence of I ng/ml TNP-KLH. The cultures
were performed in 48-replicate wells at each Th cell dose in microculture plates (3072;
Falcon Labware, Oxnard, CA). The amount of anti-TNP antibody in the culture super-
'Abbreviations used in this paper:
￿
Acc, accessory; KLH, keyhole limpet hemocyanin; IJIM, 1-j-
interacting molecule; PFC, plaque-forming cells; RAMB, rabbit anti-mouse brain serum; TsF,
suppressor Tcell factor.TABLE I
es Are Expressed on H-2"-restricted but not
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106KLH-primed 1310, BMW and B6C3F, Th cells were treated with indicatedantibody + C. The
residual cells were cocultured with 3 x 106TNP-primed BIO or BIO.BR B cellsin the presence of 1
ng/ml TNP-KLH. Bcellsalonegave no PFC.
natant was estimated by the enzyme-linked immunosorbent assay as previously described
(25). Responses that exceed the mean plus threeSD ofthe control were scored as positive.
Results
Association of IJ
k Epitopes with the H-2k Restriction Element of Th Cells in H-
2kxbF, . KLH-primed T cellsfrom B10, B10.BR, and B6C3F, mice were treated
with anti-IJ' and C, and the residual cells were cultured with TNP-primed B10
or B10.BR B cells to induce the in vitro secondary anti-TNP antibody response .
The helper function measured in this experimental condition has been known
to be dueonly to the cognate-type Th cells(19). Table I shows that the treatment
of Th cells of BIO.BR but not of B10 with three out of four anti-1-
KN34, and JKIO-23) abrogated the anti-TNP antibody formation by syngeneic
B cells. This indicates that I-j epitopes are present on the cognate-type Th cells.
F, Th cells were found to help B cells of 1310 and B10.BR equally well to
induce a comparable secondary anti-TNP antibody response (Table 1). The
helper activity restricted to BlO.BR was greatly reduced by the cytotoxic treat-
ment of F, T cells with the anti-I
Jk mAb. The same treatment of F, Th cells did
not alter the response mounted by B10 B cells, indicating that I-J' epitopes are
expressed only on I-Ak-restricted but not on I-A6-restricted Th cells in the F, T
cell population . These mAb were also able to block the I-A'-restricted helper
activity when they were simply added to the culture of F, Th and BIO.BR B cells
(data not shown).
Assignment ofIJk Epitopes on Th Cells in theMHC.
￿
To determine whether I-j
epitopes on Th cells are controlled by the I-j locus assigned with Ts and TsF
(16, 17), the cells from various congeneic and recombinant mice were tested for
the expression of I-J'. KLH-primed T cells of BI O, 3R, 4R, 5R, and B10.A were
treated with anti-I Jk mAband C, and theresidual cells were cultured with TNP-
primed syngeneic B cells in the presence of TNP-KLH. As shown in Table 11,
the helper function of T cells of BIO.A and 5R was abrogated by the treatment
with the same three of the anti-1-j' mAb (1 G8, KN34, andJK10-23), while that
of 1310, 3R, and 4R T cells was not. The results indicate that the I-j epitopes
detected by our anti-I Jk mAb on Th cells are controlled by the locus mapped at
the previously prescribed position in the MHC.
Cytotoxic
treatmentof
Th cells with:
BIO B
BIOTh
IgGanti-TNP
cells
F, Th
PFCjculture
BIO.BR
B10.BR Th
Bcells
F, Th
Control 1,445 :1- 101 1,637 ± 222 977 t 152 1,368 t 51
Anti-IJ': IG8 1,551 ± 145 1,837 t 226 205 t 74 504 t 118
41311 1,453 t 152 1,824 ± 122 940 t 68 1,272 + 78
KN34 1,464 t 257 1,881 ± 117 177 t 86 658 t 134
JKIO-23 1,560 t 139 1,761 t 102 238 t 45 304 t 62
Anti-L3T4: GK1.5 54 t 7 19 t 11 52 t 12 71 t 521616
￿
1-j EPITOPE ON T HELPER CELLS
TABLE II
1-J Epitopes on Th Cells Map Between the I-A and I-E Subregions
106KLH-primed Tcellswere treated with indicated antibody + C. Theresidual cellswere cocultured
with 3 X 106TNP-primed syngeneic Bcells in thepresence of 1 ng/ml TNP-KLH. B cells alonegave
no PFC.
TABLE III
Expression of I-J' on Th Cells of 5R but Not of 3R
106 KLH-primed B10, 3R, or 5R Th cells were treated with indicated antibody + C. The residual
cellswere cocultured with 3 X 106 TNP-primed B10 Bcells in thepresence of 1 ng/ml TNP-KLH.
B cellsalone gave no PFC.
Expression of IJk Epitopes on I-A°-restricted Th Cells in 5R but not in 3R.
￿
5R
but not 3R T cells express I Jk
(16, 17). Th cells in these recombinant strains
are, however, both I-Ab-restricted. An experiment was, therefore, carried out to
assess whether their I-Ab-restricted Th cells carry I Jk using KLH-primed Tcells
with TNP-primed B10 (H-2b) B cells. Under this condition, the expression of I-
Jk only on Th cells restricted to I-Ab is detected. The results shown in Table III
show that both 3R and 5R Th cells can provide comparable degrees of help to
B10 B cells. The helper function of 5R T cells was abrogated by the cytotoxic
treatment with anti-I Jk, whereas that of3R Th cells was unaffected. The results
indicate that Th cells of 5R but not 3R, although both are restricted to I-Ab,
express I-J' epitopes.
Both 3R and 5R Bone Marrow Stem Cells Have Potential to Express I-J* Epitopes
on Th Cells. The potential ability to express I-j epitopes on Th cells of 3R and
5R bone marrow stem cells can be determined by analyzing T cells developed
under the condition of radiation bone marrow chimera. 3R --> B10, 5R --+ B10,
3R --+ B10.A, and 5R -* B10.A chimeras were primed with KLH that had been
pulsed to the host type Acc cells. The Th cells of these chimeras were treated
with anti-l
Jk and C and were cultured with appropriate TNP-primed B cells to
Cytotoxic IgG anti-TNP PFC/culture in
treatment of TNP-primed B cellsand KLH-primed Th cells from:
Th cells with: B10 3R 4R 5R B10.A
Control 1,782 ± 4 738 t 53 1,143 ± 57 745 t 66 1,876 ± 23
Anti-IJ": 1G8 1,832 ± 83 569 ± 59 1,174 ± 15 83 ± 21 338 ± 47
4B11 1,900 ± 98 730 ± 94 1,042 ± 27 889 ± 98 1,825 ± 141
KN34 2,017 t 141 730 ± 14 1,104 ± 28 90 t 43 389 ± 57
JK10-23 1,750 ± 141 743 ± 101 1,177 ± 66 151 ± 104 406 ± 65
Anti-L3T4: GK1.5 67 ± 8 15 ± 15 17 ± 5 25 ± 25 16 ± 9
Cytotoxic
treatment of
Th cells with: B10 Th
IgG anti-TNP PFC/culture
in B10 B cells
3R Th 5R Th
Control 882± 162 781 t 104 982 t 145
Anti-IJ": 1G8 670 ± 58 889 t46 209 ± 84
4B11 889 ± 88 922 t 108 914 ± 36
KN34 871 t 150 846 t 166 378 f 20
JK10-23 939 t 166 813 t 65 315 f 91
Anti-L3T4: GK1.5 57 ± 15 50 t 29 32 ± 21ASANO ET AL.
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TABLE IV
Expression of IJk Epitopes on Th Cells of 3R and 5R Bone Marrow Cells Matured in B10.A
but notB10 Chimera Host
10' KLH-pulsed host-type Acc-primed T cells of the chimeras were treated with indicated antibody
+ C. The residual cells were cocultured with 3 X 106 TNP-primed 1310 or B10.A B cells in the
presence of 1 ng/ml TNP-KLH. B cellsalone gave no PFC.
which major MHC restriction was directed (Table IV). Th cells of 3R -+ 1110
and 5R -~ 1110 chimeras were able to help B10 B cells equally well. None of the
anti-IJk mAb was able to kill these chimeric Th cells regardless of the origin of
bone marrow cells. In contrast, the helper activity of Th cells of both 3R --*
B10.A and 5R --* BIO.A chimeras, which collaborate with B10.A B cells, was
eliminated by the cytotoxic treatment with anti-IJk. The bone marrow origin of
these chimeric Th cells was confirmed by the cytotoxic test with appropriate
anti-H-2 mAb. The results indicate that IJk epitopes are expressed on Th cells
differentiated in BIO.A but not in B10, regardless of whether they are derived
from 3R or 5R bone marrow stem cells.
I-J Haplotype of the Host Determines the Phenotype of I-J on Th Cells.
￿
To
investigate what determines the expression of IJk on Th cells, chimeras were
constructed by injecting B6AF, or (1110 X B10.A)F1 bone marrow cells into
irradiated 1110, 3R, 4R, 5R, and B10.A mice. They were primed in situ with
KLH, as all the Acc cells are of the same F, marrow origin. Th cells of these
chimeras were restricted to help B cells carrying the host-type I-A. The Th cells
obtained from these chimeras were treated with anti-IJk + C before culturing
with B10 or BlO.A B cells for the in vitro secondary antibody response. The H-
2 restriction specificity of these chimeric Th cells was directed to the host-type
I-A. As shown in Table V, three anti-IJk mAb were able to remove Th activity
of F, --* 5R and F, --> B10.A chimeric T cells even though F,
￿
5R Th cells
were able to help B10 B cells. On the other hand, Th cells of F, --~ B10 and F,
--+ 3R chimeras were not affected by anti-IJk. Furthermore, Th cells ofF, --+4R
chimeras were also insensitive to the cytotoxic treatment withanti-IJk, regardless
of their I-Ak restriction specificity. The origin of the functioning Th cells were
confirmed to be the same F, bone marrow donor origin, as determined by the
cytotoxic treatment with anti-H-2Kk (11-4.1) and anti-H-2Kb (28-13-3S). These
results indicate that the phenotypic expression of IJk on Th cells is primarily
determined by the I-J haplotype ofthe chimeric host.
I-J Phenotype of Th Is Determined by the Environmentfor Maturation but notfor
Priming T Cells. To exclude the possibility that the I-J phenotype is determined
by the environment of antigen-priming, we examined the expression of I-J on
Cytotoxic
treatment of
Th cells with:
3R--+BIOTh
1310 B
IgG anti-TNP
cells
5R-+1110Th
PFC/culture
BI O.A
3R--* BIO.ATh
B cells
5R~B10.ATh
Control 613 ± 48 547 ± 64 647 ± 29 780 ± 140
Anti-I,J°: 1G8 520 ± 46 673 t 37 153 ± 153 347 t 18
JKIO-23 600 ± 20 540 t 60 47 t 24 147 t 24
Anti-D': H141-30 613 ± 13 687 ± 24 ND ND
Anti-Kb: 28-13-3S ND ND 13 ± 13 27 t 271618
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Cytotoxic
treatment of
Th cellswith:
TABLE V
I-J Genotype ofChimeraHost Determines thePhenotype ofI-J on Th Cells
106 KLH-primed B6AF, --)- B10, B6AF, -+ BIO.A, B6AF, -* 3R, B6AF, -->4R, and B6AF, --* 5R
chimera Th cells were treated with anti-1-J' + C. The residual cells were cocultured with 3 x 106
TNP-primed B10 or BIO.A Bcells in thepresence of I ng/ml TNP-KLH. Bcellsalone gave no PFC.
All Th cells used were restricted to help host- butnot nonhost-type B cells.
TABLE VI
I-J Phenotype ofa Th Cell Is Determined by the Maturation but not by the Priming
Environment
IgG anti-TNP PFC/culture
B10 Bcells
￿
BIO.A B cells
F, (B10) Th
￿
F, (3R) Th
￿
F, (5R) Th
￿
F, (4R) Th
￿
F, (B10.A)
Th
Control
￿
633 t 29
￿
687 ± 77
￿
667 ± 114
￿
493 t64
￿
400 t 64
Anti-1-J':
￿
1G8
￿
680 ± 12
￿
660 t 70
￿
593 t 74
￿
27 t 13
￿
33 t 33
JKIO-23
￿
600 t 46
￿
560 ± 50
￿
547 t 77
￿
27 t 27
￿
20 ± 20
Anti-L3T4: GK1.5
￿
0
￿
7 ± 7
￿
0
￿
0
￿
0
106 KLH-pulsed (indicated in parentheses) Acc-primed B6AF, T cells were treated with indicated
antibody + C. The residual cells were cocultured with 3 x 106 TNP-primed B10or BIO.A B cellsin
the presence of 1 ng/ml TNP-KLH. Th cells did not provide help to B cells of the I-A haplotype,
which were not used for priming. Bcells alonegave no PFC.
Th cells of (B10 X BIO.A)F, mice that had been primed with KLH-pulsed Acc
cells of different haplotype origin . Acc cells from 1310, 3R, 4R, 5R, and B10.A
were pulsed in vitro with KLH and then injected into F, mice. Under this
condition ofpriming, no allogeneic effects are expected. Th cells thus obtained
were treated with anti-1-J and examined for ability to help TNP-primed B10 or
B10.A B cells. As shown in Table V1, the F, Th cells primed with KLH-pulsed
Acc cells of B10, 3R, and 5R were able to help B10 but not B10.A B cells. On
the other hand, F, Th cells primed on 4R and B10.A Acc cells could help only
B10.A but not B10 B cells, indicating that the priming with KLH in context of
the given I-A molecule on Acc cells determines the H-2 restriction offunctioning
Th cells (Table VI). When these Th cells were treated with anti-I Jkand C, those
restricted only to I-Ak were sensitive to the treatment regardless of the absence
or presence ofIJk on Acc cells used forpriming. Also, phenotypeofI-J subregion
of priming Acc cells did not determine the IJk expression on I-Ab-restricted F,
Th cells. The observed pattern of IJk expression on F, Th was identical to that
IgG anti-TNP PFC/culture
Cytotoxic B10 Bcells BIO.A B cells treatment of
Th cells with:
F,-.B10Th F,~3RTh F,-*5RTh F,~4RTh F,-"BIO.A
Th
Control 2,116 f 50 1,428 ± 95 1,554 ± 17 2,285 ± 113 1,764 ± 22
Anti-IJ": 1G8 2,250 t 63 1,159± 29 302 ± 14 1,958 ± 9 739 f 73
4B11 2,469 t 150 1,411 ± 44 1,494 t 61 2,184 ± 51 1,855 t 122
KN34 2,149 t 144 1,512 ± 109 370 ± 77 2,084 t 53 646 t 134
JKIO-23 2,318 ± 169 1,260± 104 446 ± 103 2,066 ± 116 646 t 49
Anti-K': 11-4.1 42 ± 17 32 ± 4 50 ± 8 ND ND
Anti-Kb: 28-13-3S ND ND ND 42 t 12 21 ± 7ASANO ET AL.
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TABLE V11
An MHC-restriction Specificity and an 1-JPhenotype Are Expressed on a Th Cell in a Cis but
Not a TransFashion
Origin of
￿
Cytotoxic treatment
F, Th cells
￿
ofTh cellswith:
IgGanti-TNP PFC/culture in
F, Th cells cocultured with:
1310 B cells
￿
5R B cells
￿
4R B cells
￿
BIO.A B cells
(1310 X B10A)F,
￿
Control
￿
2,889 ± 131
￿
904 t 93
￿
907 t43
￿
1,008 t 58
Anti-IJ":
￿
IG8
￿
2,310 t 163
￿
1,016 t 220
￿
210 ± 66
￿
134 ± 73
(411 X 5R)F,
Anti-L3T4: GKI.5
￿
25 ± 14
￿
0
￿
0
￿
50 t 50
106 KLH-primed (1310 X B10.A)F, or (4R X 5R)F, Th cells were treated with indicated antibody +
C. The residual cells were cocultured with 3 X 106 TNP-primed 1110, 5R, 4R, and B10.A B cells in
thepresence of I ng/ml TNP-KLH. B cells alone gave no PFC.
ofF, Th primed in situ, regardless of the haplotype origin of Acc cells used for
priming. The results indicate that 1-j epitopes expressed on Th cells are deter-
mined primarily by the maturation environment before the priming.
MHC Restriction Specificity and I-j Phenotype on Th Cells Show Only Cis Expres-
sion. Therelationship betweenan MHC restriction specificity and I-j phenotype
was studied in (1310 X B10.A)F, and (4R X 5R)F, Th cells. KLH-primed Th cells
from these mice were treated with anti-1-j' + C followedby coculture with TNP-
primed B10, 4R, 5R, and B10.A B cells. The results are summarized in Table
VII. Th cells from (1310 X Bl0.A)F, were able to help B cells ofall these strains
with different H-2-restriction specificity; I-Ab-restriction to help B10 and 5R B
cells, and I-Ak-restriction to help 4R and B10.A B cells. The treatment ofF, Th
cells with anti-I Jk eliminated with I-Ak restricted Th function leaving the I-Ab-
restricted function intact. When Th cells of (4R X 5R)F, were treated by the
same anti-I Jk mAb, only the I-Ab-restricted Th function was affected. The same
anti-l Jk mAb did notalter the response inducedby the I-Ak-restrictedTh of(4R
X 5R)F,. The results indicate that only the combinations of I-A-restriction and
l-j expression represented in parental haplotypes are expressed among F, Th
populations.
This was further confirmed by the limiting-dilution analysis using (1310 X
B10.A)F, Th cells. Graded numbers of(1310 X B10.A)F, Th cells were cultured
with TNP-primed 1110 or 4R B cells to enumerate I-Ab- and I-Ak-restricted Th
cells, respectively. The frequency of Th cells with I Jk epitopes on a functioning
site was estimated in the presence ofanti-I Jk in limiting-dilution cultures. Fig. 1
shows the frequency analysis of I-Ab- and I-Ak-restricted Th cells in the presence
and absence of anti-I Jk or anti-L3T4. The frequency of KLH-specific, I-Ab-
restricted Th cells, which cooperated with B10 B cells, was 1 in 6.2 X 104. This
frequency was not altered in the presence of anti-I Jk (1 in 6.1 X 104). The
frequency ofKLH-specific, I-Ak-restricted Th cells estimated with 4R B cells was
1 in 5.3 X 104, the frequency ofwhich was reduced to 1 in 4.6 X 105 when anti-
Anti-L3T4:
JKIO-23
GK1.5
3,024 ± 227
117 ± 60
915 t 132
42 t 22
159 ± 55
0
159 t 16
0
Control 1,310 t 81 705 t 52 1,621 t84 1,394 t 111
Anti-IJ4: IG8 344 ± 60 50 t 14 1,528 ± 198 1,276 ± 137
JKIO-23 268 t 117 67 ± 22 1,646 t 74 1,327 t 2261620
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F, T cells added (x
10-4)
4 6 8 10 12
FIGURE 1 .
￿
The limiting-dilutionanalysis of I-
J°-positive cells in (B10 X B10.A)F, Th cell
subpopulations. Graded numbers of KLH-
primed (1310 XB10.A)F,Th cellswere cultured
with 5 X 105 TNP-primed B10 (O, A, [1) or 411
(0, A, /) B cells in the presence of I ng/ml
TNP-KLH. The parallel cultures were carried
out in the absenceof antibody (O, 0) or in the
presence of 10% culture supernatant of anti-1-
J' (JK10-23) (A,A) or 10% culture supernatant
ofanti-L3T4 (0,/) in 48 replicate wellsat each
Th cell dose in microculture plates. The
amount of anti-TNP antibody in the culture
supernatant was estimated by the enzyme-
linked immunosorbent assay. Responses that
exceed the mean plus three SD of the control
were scored as positive.
I Jk was present in the culture. This reduction of the frequency in the functional
Th was comparable with that induced by anti-L3T4. An additional experiment
with (BIO X B10.BR)Fl Th cells gave essentially the similar pattern (data not
shown). These results indicate that there is no detectable number of Th cells
bearing I-J' in I-A'-restricted Th cell population in (1110 X BIO.A)F1 and (1110
X B10.BR)Fl .
Discussion
Previous studies in this series (16, 17) indicated that some of the anti-la mAb
raised by the combination of I region-incompatible strains of mice did not bind
to class II antigens but reacted with the site on T cells involved in the MHC-
restricted cell interaction. These antibodies were reactive only with T cells but
not with B cells and macrophages, and thus were designated as anti-Iat antibodies
(26, 27). They were able to block class II-restricted macrophage-T cell and T-
B cell interactions, resulting in the inhibition of the in vitro secondary antibody
response (16, 17). The target site of these antibodies are detected on Th cells of
F, animals restricted to only one parental strain of mice but not to the other,
and can be adaptively acquired by Th cells of different genotype origin when
developed in radiation bone marrow chimeras (17). These results indicated that
lat antigens are not the direct products of class II genes but are associated with
a structure on T cells that sees the MHC polymorphism.
I-j is in many respects analogous to Iat, as it is expressed only on functional T
cells (5). Although IJ was first demonstrated on Ts and TsF (1, 2), it has been
detected on a variety of T cell subsets including Th, Ts-inducer, and MLR
responders (15, 28-31). It has recently been demonstrated that IJ can be
adaptively expressed by T cells of different genotype that have developed in the
radiation bone marrow chimera and in transgenic mice (29-32). The present
experiments were undertaken to elucidate the nature of I-j in the light of
adaptive changes of restriction specificity in bone marrow chimeras. A newly
established anti-IJ mAbJK 10-23 was used to study the expression of I-j on Th,
as this mAb was able to absorb TsF and to kill Th of H-2k origin.ASANO ET AL.
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Four essential findings were obtained: first, I Jk epitopes are expressed on Th
cells of H-2kxbF, mice restricted to help H-2k B cells, but not on those restricted
to H-2b Bcells. This was demonstrated by both the elimination ofH-2'-restricted
Th by the anti-I Jk + C and the blocking of H-2k-restricted Th activity without
C. The same treatments of F, Th cells with anti-I Jk did not alter the helper
activity for H-2b B cells, indicating that IJk is exclusively expressed on H-2k-
restricted Th of H-2kxbF, spleen cells. The limiting-dilution analysis of IJk-
positive Th cells in (B10 x BIO.A)F, capable ofhelping 4R B cells indicated that
virtually all I-Ak-restricted Th cells carry the I Jk epitope. This suggested that I-
Jk epitopes are associated with the H-2k restriction site ofTh cells.
However, there was noabsolute association between the I-J phenotype and the
MHC restriction specificity. I Jk was found on Th ofBIO.BR and BIO.A having
the H-2k restriction specificity, whereas Th from 4R having the same H-2k
restriction specificity was not killed by the anti-I Jk. Furthermore, Th cells of 5R
were shown to be positive for I Jk regardless of the fact that they are H-2b-
restricted. The same H-2b-restricted Th of both 3R and of B10 were absolutely
negative for I Jk. The results bring us back to the original mapping of I-J in
between I-A and I-E based on the genetic studies (1, 2).
Third, all above findings were verified in radiation bone marrow chimeras,
where these recombinant mice were used as recipients ofbone marrow stem cells
ofdifferent genotypes. Without exception, the restriction specificity of Th cells
followed the host type, and the I-J expression on Th was exactly the same as that
expected for the host haplotype. By examining the I-J expression of Th cells of
F, -4 recombinant chimeras, where Th cells were primed with the identical F,-
type antigen-presenting cells (APC), the I-J expression ofat least Th cells is solely
determined by the selection in the thymic environment, rather than by priming
with APC.
The final most striking finding is the linked expression of the parental H-2
restriction specificity and the I-J phenotype in the F, Th cell population . This
was best exemplified in Th cells in (4R x 5R)F,, where Th cells were either H-
2k_ or H-2b-restricted. IJk was found only on H-2b-restricted but not on H-2k-
restricted Th cells. As H-2b restriction specificity was a trait possessed by 5R, the
strain with I Jk, there was an absolute linkage between the restriction specificity
and the I-J phenotype in F, Th cells. Ifwe refer to the original mapping of I-J,
the results obtained here indicate that there is only a cis expression of the
restriction specificity and I-J phenotype in the F, (e.g., 5R has the linked
expression ofI-Ab and I Jk, and4R, I-Ak and I-Jb). Theexperimentswith chimeras
also support the notion that there is no case where expression ofI Jk is associated
with MHC restriction other than that originally possessed by the host.
All these results indicate that I-J is an isomorphic structure T cells acquire in
conjunction with their H-2 restriction during early differentiation in the thymus.
I-J is probably directly involved in the MHC-restricted cell interaction, as anti-1-
J mAb can block the response. The simplest deduction is that I-J is an inducible
T cell receptor for the self class II polymorphism, which is involved in the T
cells' H-2-restricted functions.
However, the present results indicate that the I-J isomorphism does not always
correlate with the specificity of the MHC restriction. The Th of 5R restricted to1622
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I-Ab expressed I Jk, whereas the H-2k-restricted 4R Th lacked I-J'. TheTh from
3R and 5R differed in I-j phenotype regardless of their identical I-A' restriction
specificity . Therefore, I Jk does not always reflect the H-2k restriction specificity .
On the other hand, the parental restriction specificity and the I-j phenotype
were always coexpressed in F, T cells. If the expression of I-j is merely due to
an educational process in T cells according to the class 11 expression of the
thymic environment, there should be F, T cells with I-j expression associated
with the both parental H-2 restriction specificities . The absence of IJk-positive
T cells having the opposite I-Ab restriction specificity in the (BIO X B10.A)F,
suggests that the I-j isomorphism is physically associated with, or even identical
to, the MHC restriction site ofT cells . However, I-j isomorphic structure does
not correspond to the given restriction specificity .
Although we do not want to reiterate the debates on the nature of I-j molecule
(reviewed in 33 and 34), we have to examine here a few critical points . Is I-j
indeed associated with the known T cell receptor (TcR)? There are very little
biochemical data available to verify or disprove the identity of I-j determinants
as a substructure of TcR (35, 36) . The discrepancy between the I-j phenotype
and the restriction specificity in recombinant mice, as well as their exclusive cis
expression in F, suggests that I-j is not merely the epitope on the anti-MHC
portion ofTcR. Although it is related to the acquirable restriction specificity of
T cells, it does not directly correlate with the specificity per se .
Second, what does the I-j represent? The prevalence of the I-j among class II-
restricted population ofTcells indicates that I-j is an isomorphic structure shared
bya largepopulation ofTcells having class 11 MHC-restricted functions involved
either in help or suppression . Our more recent results indicated that the gener-
ation of both suppressor and augmenting regulatory T cells was inhibitable by
the administration of the anti-IJ mAb into the in vitro culture of primed
lymphocytes (37) . It has been known that I-j is predominantly expressed on Ts
cells (1-10, 33, 34), while it has become clear that other regulatory T cells,
including Th, also carry I-j epitopes . Detailed information about the identity of
I-j on Th and Ts is still lacking . In addition, the mode of acquisition ofMHC
restriction by Th and Ts seems to be different . However, since these regulatory
T cells are selectively interacting with specified target cells, the isomorphism of
I-j should be an ideal device to direct the cell interactions . Thus, the I-j appears
to be involved in the construction of MHC-restricted regulatory circuits .
Finally, the origin of IJ polymorphism is still unknown . The present results
indicated that both class II and TcR genes by themselves do not explain the I-j
specificity (see above discussion) . Recently, Kawasaki and colleagues (38) dem-
onstrated that the antiidiotypic reagent against a monoclonal anti-IJ inhibited
the induction of IJ+ Ts by reacting with APC and B cells . The target of
antiidiotype of I-j was not class II antigen, and hence was designated as I+
interacting molecule (IJIM) . As we cannot find the direct correlation between
H-2 restriction specificity and I-J, a possibility should be considered that MHC
polymorphism generates a second-order polymorphic structure, such as IJIM on
APC and thymic cells, that dictates the I-j epitope . The linked inheritance of IJ
restriction specificity in F, suggests that such aputative IJIM should be influenced
by the class 11 antigen .Although the gene transfer experiments demonstrated that the conventional
TcR «/,Q heterodimer can explain both the MHC restriction and antigen-
specificity (39, 40), the presence of additional polymorphic structure having a
broad MHC restriction specificity has not been excluded. We may refer to some
studies that proposed the two-receptor model for MHC plus antigen and MHC
alone (41). The present results with anti-IJ also encourage further study of the
specialized MHC restriction site associated with or in addition to the known TcR
molecules.
The I-j enigma is one of the first-rated paradoxes in current cellular immu-
nology and immunogenetics. Not much progress hasbeen made in the molecular
genetics ofmembrane biochemistry, despite numerous efforts. Nevertheless, the
I-j issue provides important clues to study the mechanism whereby T cells
recognize the right partner cells with which to interact for the construction of
regulatory circuits.
Summary
I-j epitopes were found to be associated with the functional site ofthe class II
MHC-restricted helper T (Th) cells: Virtually all of the H-2k-restricted Th cell
function of H-2kxbF, T cells was inhibited by the anti-I Jk mAb, leaving the H-
2b-restricted function unaffected. The IJk epitope was inducible in Th cells of
differentgenotypeorigin accordingtothe environmental class II antigens present
in the early ontogeny ofTcells. Although above results suggested that I-j is the
structure reflecting the inducible MHC restriction specificity, further studies
revealed some interesting controversies: First, the I-j phenotype did not always
correlate with the class II restriction specificity, e.g., I-Ab-restricted Th from 5R
was I-J'-positive, whereas I-Ak-restricted Th of 411 was not. Second, there was
no trans expression of parental I-j phenotypes and restriction specificities in F,
Th, e.g., the I-j phenotype was detected only on I-Ab-restricted Th of (4R X
5R)F,, whereas it was absent on I-Ak-restricted Th. This strict linkage between
the restriction specificity and I-j phenotype was also foundon Th cells developed
in bone marrow chimera constructed with intra-H-2-recombinant mice. The
expression of IJk was always associated with the restriction specificity of the
relevant host. Thus, the restriction specificity of Th cells followed the host type,
and the I-j expression on Th was exactly the same as that expressed by the host
haplotype. These results indicate that I1 is an isomorphic structure adaptively
expressed on Th cells that is involved in the unidirectional regulatory cell
interactions, and that the polymorphism cannot be explained merely by the
restriction specificity of the conventional Tcell receptor heterodimer.
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